Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 30 for pancreatic cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study Of Nuzefatide Pevedotin (BT5528) In Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. KO-2806 Monotherapy And Combination Therapies In Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Stereotactic Adaptive Radiation Therapy Of Borderline Resectable Pancreatic Cancer An Individualized Approach

    Rochester, MN

  5. Pancreatic Cancer Detection Consortium

    Rochester, MN

  6. Prospective Pancreatic Cancer Precision Oncology Treatment Outcomes Registry (PROCTOR)

    Rochester, MN

  7. Prospective Pancreatic Cancer Precision Oncology Treatment Outcomes Registry

    Rochester, MN

  8. Resectable, Borderline Resectable, And Locally Advanced Pancreatic Cancer Biorepository Of Peripheral Blood

    Rochester, MN

  9. A Study Of PRIME Model To Identify High-Risk Individuals For Pancreatic Cancer Screening

    Rochester, MN

  10. A Study Of Pancreatic Cancer Voice Signature (PanVoS)

    Jacksonville, FL

.

Mayo Clinic Footer